Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.

Archives of endocrinology and metabolism - 1 Jan 2000

Andrade Matheus de Oliveira, Cunha Vinícius Santos da, Oliveira Dayana Carla de, Moraes Olívia Laquis de, Lofrano-Porto Adriana

Abstract excerpt

Pheochromocytoma (PCC) is a tumor derived from adrenomedullary chromaffin cells. Prognosis of malignant PCC is generally poor due to local recurrence or metastasis. We aim to report a case of malignant PCC with 18-year survival and discuss which factors may be related to mortality and long-term survival in malignant pheochromocytoma. The patient, a 45-year-old man, reported sustained arterial hypertension with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MAX gene

Share to Mutation

Share to Pheochromocytoma

Share to Prognosis

Share to Time Factors

Share to Tomography, Emission-Computed, Single-Photon

Source

Open in PubMed Open full text

Identifiers

PMID: 29768630
DOI: 10.20945/2359-3997000000033
PMCID: PMC10118982

Genes

MAX
SDHB
SDHC
SDHD
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.PMID 29768630Read ↗

Malignant pheochromocytoma.Semantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Metastatic Pheochromocytoma and Paraganglioma: Clinicopathological Analysis of 35 CasesSemantic proximity Read ↗

Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Type of manuscrit : Original articles Titre: Clinical and Therapeutic Profile of Pheochromocytomas and Paragangliomas: A 20- Year Cohort from AlgeriaSemantic proximity Read ↗

Pheochromocytoma: current approaches and future directions.Semantic proximity Read ↗

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or ParagangliomasSemantic proximity Read ↗

Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas.Semantic proximity Read ↗

Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.Semantic proximity Read ↗

Paraganglioma Presenting Atypical Initial Symptoms: a Case ReportSemantic proximity Read ↗

Long-term prognosis of patients with pediatric pheochromocytoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.